Quantifying systemic molecular networks affected during high altitude de-acclimatization.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
07 09 2023
Historique:
received: 11 07 2022
accepted: 13 08 2023
medline: 11 9 2023
pubmed: 8 9 2023
entrez: 7 9 2023
Statut: epublish

Résumé

High altitude acclimatization and disease have been the centerpiece of investigations concerning human health at high altitude. Almost all investigations have focused on either understanding and ameliorating high altitude disease or finding better methods of acclimatization/training at high altitude. The aspect of altitude de-induction/de-acclimatization has remained clouded despite the fact that it was documented since the first decade of twentieth century. A few recent studies, particularly in China, have stated unanimously that high altitude de-acclimatization involved multiple observable clinical symptoms ranging from headache to abdominal distention. These symptoms have been collectively referred to as "high altitude de-acclimatization syndrome" (HADAS). However, computational omics and network biology centric investigations concerning HADAS are nascent. In this study, we focus on the quantitative proteo-informatics, especially network biology, of human plasma proteome in individuals who successfully descended from high altitude areas after a stay of 120 days. In brief, the protein list was uploaded into STRING and IPA to compute z-score based cut-offs which were used to analyze the directionality and significance of various identified protein networks as well as the proteins within them. Relevant upstream regulators extracted using computational strategies were also validated. Time-points till the 180th day of de-induction have been investigated to comparatively assess the changes in the plasma proteome and protein pathways of such individuals since the 7th day of arrival at altitude. Our investigation revealed extensive effects of de-induction on lipid metabolism, inflammation and innate immune system as well as coagulation system. This novel study provides a conceptual framework for formulating therapeutic strategies to ease the symptoms of HADAS during de-acclimatization. Such strategies should focus on normalization of lipid metabolism, inflammatory signaling and coagulation systems.

Identifiants

pubmed: 37679378
doi: 10.1038/s41598-023-40576-w
pii: 10.1038/s41598-023-40576-w
pmc: PMC10484924
doi:

Substances chimiques

Proteome 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

14768

Informations de copyright

© 2023. Springer Nature Limited.

Références

Circulation. 1978 Jun;57(6):1180-5
pubmed: 346260
Jpn J Physiol. 1988;38(4):557-62
pubmed: 3236574
J Appl Physiol (1985). 2014 Apr 1;116(7):858-66
pubmed: 24371017
J Med Chem. 2007 Sep 6;50(18):4543-7
pubmed: 17676725
PLoS One. 2013 May 01;8(5):e62072
pubmed: 23650508
Eur J Appl Physiol Occup Physiol. 1998;77(1-2):37-43
pubmed: 9459519
Mil Med Res. 2018 Jan 24;5(1):2
pubmed: 29502526
PLoS One. 2012;7(2):e31097
pubmed: 22363556
High Alt Med Biol. 2018 Mar;19(1):4-6
pubmed: 29583031
Antioxid Redox Signal. 2020 Jun;32(18):1330-1347
pubmed: 31218894
Int J Sports Med. 1997 Apr;18(3):179-85
pubmed: 9187971
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
Mediators Inflamm. 2016;2016:1732352
pubmed: 27190491
J Physiol. 1908 Dec 15;37(5-6):378-89
pubmed: 16992939
Eur J Appl Physiol Occup Physiol. 1996;73(6):529-35
pubmed: 8817123
J Physiol. 2003 Feb 1;546(Pt 3):921-9
pubmed: 12563015
Pain. 2002 Mar;96(1-2):99-105
pubmed: 11932066
Acta Neurol Scand. 1993 Feb;87(2):103-5
pubmed: 8442391
High Alt Med Biol. 2019 Sep;20(3):236-244
pubmed: 31210541
Br Heart J. 1978 Mar;40(3):276-85
pubmed: 637981
Br J Pharmacol. 2018 Jun;175(12):2219-2230
pubmed: 28728214
PLoS One. 2014 Oct 01;9(10):e108788
pubmed: 25271637
Eur J Appl Physiol Occup Physiol. 1991;62(2):73-6
pubmed: 2022206
Dev Cell. 2014 Feb 10;28(3):239-52
pubmed: 24486154
J Immunol Res. 2019 Nov 15;2019:4521231
pubmed: 31828172

Auteurs

Subhojit Paul (S)

Peptide & Proteomics Division, Defence Institute of Physiology & Allied Sciences (DIPAS), Defence R&D Organization (DRDO), Timarpur, New Delhi, 110054, India.

Shikha Jain (S)

Peptide & Proteomics Division, Defence Institute of Physiology & Allied Sciences (DIPAS), Defence R&D Organization (DRDO), Timarpur, New Delhi, 110054, India.

Anamika Gangwar (A)

Peptide & Proteomics Division, Defence Institute of Physiology & Allied Sciences (DIPAS), Defence R&D Organization (DRDO), Timarpur, New Delhi, 110054, India.

Swaraj Mohanty (S)

Peptide & Proteomics Division, Defence Institute of Physiology & Allied Sciences (DIPAS), Defence R&D Organization (DRDO), Timarpur, New Delhi, 110054, India.

Nilofar Khan (N)

Peptide & Proteomics Division, Defence Institute of Physiology & Allied Sciences (DIPAS), Defence R&D Organization (DRDO), Timarpur, New Delhi, 110054, India.

Yasmin Ahmad (Y)

Peptide & Proteomics Division, Defence Institute of Physiology & Allied Sciences (DIPAS), Defence R&D Organization (DRDO), Timarpur, New Delhi, 110054, India. yasminchem@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH